What is the level of liabilities of Amedisys this year?
Amedisys has a debt balance of 993.66 M USD this year.
Amedisys Liabilities 2024
Amedisys Liabilities
993.66 M USD
Ticker
AMED
ISIN
US0234361089
WKN
915582
In 2024, Amedisys's total liabilities amounted to 993.66 M USD, a 7.46% difference from the 924.7 M USD total liabilities in the previous year.
Amedisys Aktienanalyse
What does Amedisys do?
Amedisys Inc is a US home healthcare provider that offers a variety of healthcare services in the private home, including home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. The company was founded in 1982 by William F. Borne and Michael J. Borne and is headquartered in Baton Rouge, Louisiana. History In the 1980s, while William and Michael Borne were running a nursing home together, they recognized a demand for home healthcare and founded Amedisys in 1982. The company started with a small group of nurses making house calls and was based on the belief that people would prefer to be cared for at home rather than being placed in a facility. In 1999, Amedisys was acquired by the American Stock Exchange and was able to steadily improve its performance and expand its business model to multiple states. In 2007, the company went public and has been listed on NASDAQ since. Business Model Amedisys offers a wide range of healthcare services that are typically received by patients at home. The services include home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. Amedisys collaborates with over 360 medical faculties and over 7,500 medical professionals who provide healthcare to over 385,000 patients per year. Amedisys also offers training programs for nurses and other employees to discover the business and potential growth opportunities. The company relies on teamwork to motivate staff and keep their knowledge and skills up-to-date. Segments Amedisys operates in two main business segments: home healthcare and hospice care. Both segments offer specialized services and are provided by professionals such as registered nurses, therapists, medical assistants, and social workers. The company has more than 435 hospice facilities in 34 US states and over 197 home healthcare branches in 38 US states. Products Amedisys offers a variety of products, including infusion therapy, professional wound management, clinical respiratory therapy, polypharmacy management, specialized care services, and palliative care. The company also provides telemedicine options for patients to receive care from home. Summary Amedisys is a leading provider of home healthcare and hospice care in the US. The company offers a wide range of services and is able to serve both the inpatient and outpatient settings. The company relies on teamwork to provide comprehensive and high-quality care to patients. Amedisys is a successful and expanding company that is also exploring new market potentials through the use of technology. Amedisys ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Amedisys's Liabilities
Amedisys's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Amedisys's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Amedisys's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Amedisys's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Amedisys’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Amedisys stock
What were the liabilities of Amedisys compared to the previous year?
The liabilities of Amedisys have increased by 7.46% increased compared to the previous year.
What are the consequences of high debt for investors of Amedisys?
High liabilities can pose a risk for investors of Amedisys, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Amedisys?
Low liabilities mean that Amedisys has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Amedisys affect the company?
An increase in liabilities of Amedisys can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Amedisys affect the company?
A decrease in the liabilities of Amedisys can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Amedisys?
Some factors that can influence the liabilities of Amedisys include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Amedisys so important for investors?
The liabilities of Amedisys are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Amedisys take to modify the liabilities?
To change its liabilities, Amedisys can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Amedisys pay?
Over the past 12 months, Amedisys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amedisys is expected to pay a dividend of 0 USD.
What is the dividend yield of Amedisys?
The current dividend yield of Amedisys is .
When does Amedisys pay dividends?
Amedisys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Amedisys?
Amedisys paid dividends every year for the past 0 years.
What is the dividend of Amedisys?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Amedisys located?
Amedisys is assigned to the 'Health' sector.
Wann musste ich die Aktien von Amedisys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Amedisys from 9/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.
When did Amedisys pay the last dividend?
The last dividend was paid out on 9/26/2024.
What was the dividend of Amedisys in the year 2023?
In the year 2023, Amedisys distributed 0 USD as dividends.
In which currency does Amedisys pay out the dividend?
The dividends of Amedisys are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Amedisys stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Amedisys
Our stock analysis for Amedisys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amedisys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
